Clinical trial
Rotigotine Restless Legs Syndrome Dose Finding Trial
NCT00243217 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00243217 |
|---|---|
| Title | Rotigotine Restless Legs Syndrome Dose Finding Trial |
| Official title | Multi-center, Double-blind, Randomized, Placebo-controlled, Six-arm, Parallel-group, Dose-finding Trial to Determine Efficacy, Safety and Tolerability of Five Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Idiopathic Restless Leg Syndrome |
| Intervention type | Drug |
| Interventions | SPM 936 |
| Enrollment | 341 |
| Start date | Apr 1, 2003 |
| Primary completion | Feb 1, 2004 |
| Completion | Feb 1, 2004 |
| First posted | Oct 21, 2005 |
| Last update posted | Sep 25, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: